Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3913]

Study of quadruple combination for induction resistant myeloma reveals novel...

Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints ( Dr Yael Cohen - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel )

Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma

Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA

Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma ( Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA )

Eligibility criteria in acute myeloid leukaemia clinical trials

Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA

Eligibility criteria in acute myeloid leukaemia clinical trials ( Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA )

Azacitidine plus nivolumab in older adults with AML or MDS

Prof Annette Hay - Queen's University, Ontario, Canada

Azacitidine plus nivolumab in older adults with AML or MDS ( Prof Annette Hay - Queen's University, Ontario, Canada )

Cancer Survivorship - Special Issue

Prof Deborah Fenlon - Swansea University, Swansea, UK

Cancer Survivorship - Special Issue ( Prof Deborah Fenlon - Swansea University, Swansea, UK )

Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause...

Prof Deborah Fenlon - Swansea University, Swansea, UK

Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors ( Prof Deborah Fenlon - Swansea University, Swansea, UK )

Precision medicine treatment in older AML: Results of Beat AML master trial

Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA

Precision medicine treatment in older AML: Results of Beat AML master trial ( Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA )

Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T...

Dr Karl Kilgore - Avalere Health, Bowie, USA

Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-cell therapy ( Dr Karl Kilgore - Avalere Health, Bowie, USA )

CARTITIUDE-1: BCMA-targeted CAR T-cell therapy shows high response rates in...

Prof Deepu Madduri - Mount Sinai, New York, USA

CARTITIUDE-1: BCMA-targeted CAR T-cell therapy shows high response rates in patients with multiple myeloma ( Prof Deepu Madduri - Mount Sinai, New York, USA )

Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse...

Dr Patrick Brown - Johns Hopkins University, Baltimore, USA

Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse of B-ALL in children and adolescents ( Dr Patrick Brown - Johns Hopkins University, Baltimore, USA )

Identifying prognostic constellations of driver mutations in acute myeloid...

Dr Charles Mullighan - St. Jude Children's Research Hospital, Memphis, USA

Identifying prognostic constellations of driver mutations in acute myeloid leukaemia and myelodysplastic syndromes ( Dr Charles Mullighan - St. Jude Children's Research Hospital, Memphis, USA )

CANDOR: Triple drug combo delays disease progression in stubborn multiple...

Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA

CANDOR: Triple drug combo delays disease progression in stubborn multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )

More from ecancer